Harald Renz Selected Research

Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)

12/2010	Development and validation of a combined method for the biomonitoring of omega-3/-6 fatty acids and conjugated linoleic acids in different matrices from human and nutritional sources.
11/2007	Development of mucosal immune function in the intrauterine and early postnatal environment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Harald Renz Research Topics

Disease

78	Asthma (Bronchial Asthma) 01/2022 - 06/2002
43	Inflammation (Inflammations) 01/2022 - 09/2002
39	Hypersensitivity (Allergy) 01/2022 - 03/2002
11	Infections 01/2022 - 02/2003
10	Respiratory Hypersensitivity 05/2015 - 02/2003
9	COVID-19 01/2022 - 01/2020
9	Atopic Dermatitis (Atopic Eczema) 01/2021 - 02/2003
8	Food Hypersensitivity (Food Allergy) 12/2021 - 01/2005
7	Eosinophilia 01/2022 - 05/2003
6	Neoplasms (Cancer) 01/2021 - 01/2012
5	Pneumonia (Pneumonitis) 01/2022 - 05/2005
5	Allergic Rhinitis 01/2022 - 05/2005
4	Human Influenza (Influenza) 01/2022 - 01/2018
3	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 01/2021
3	Virus Diseases (Viral Diseases) 01/2021 - 06/2007
3	Colitis 01/2018 - 01/2017
3	Airway Remodeling 01/2014 - 01/2007
3	Hyperplasia 01/2014 - 04/2005
2	Severe Acute Respiratory Syndrome 01/2022 - 01/2021
2	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2020
2	Necrosis 01/2022 - 01/2017
2	Eczema 12/2021 - 04/2008
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2021 - 01/2021
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 11/2011
2	Obesity 01/2021 - 01/2015
2	Disease Progression 01/2020 - 12/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 07/2014
2	Respiratory Sounds (Crackle) 01/2018 - 10/2015
2	Noncommunicable Diseases 01/2016 - 01/2015
2	Immediate Hypersensitivity 03/2010 - 10/2009
2	Autoimmune Diseases (Autoimmune Disease) 06/2007 - 02/2003
2	Communicable Diseases (Infectious Diseases) 10/2006 - 03/2002
2	Airway Obstruction (Choking) 02/2004 - 05/2003
2	Lung Diseases (Lung Disease) 12/2003 - 06/2002
2	Metaplasia 06/2003 - 05/2003
1	Critical Illness (Critically Ill) 01/2022
1	Pain (Aches) 01/2022
1	Edema (Dropsy) 01/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022

Drug/Important Bio-Agent (IBA)

47	AllergensIBA 01/2022 - 09/2002
19	CytokinesIBA 01/2022 - 06/2003
19	Immunoglobulin E (IgE)IBA 01/2022 - 09/2002
14	AntibodiesIBA 01/2022 - 09/2002
13	Nerve Growth Factors (Neurotrophins)IBA 01/2012 - 02/2003
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2004
10	Catalytic DNA (Deoxyribozyme)IBA 01/2018 - 04/2008
10	Nerve Growth Factor (NGF)IBA 01/2012 - 09/2002
8	OvalbuminIBA 01/2018 - 09/2002
7	Immunoglobulin G (IgG)IBA 01/2022 - 05/2003
7	AntigensIBA 01/2020 - 03/2002
7	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2006 - 05/2003
6	AutoantibodiesIBA 01/2022 - 10/2004
6	AutoantigensIBA 01/2022 - 10/2004
6	Interleukin-5 (Interleukin 5)IBA 01/2020 - 06/2003
6	AcidsIBA 01/2017 - 01/2007
5	Histones (Histone)IBA 10/2020 - 07/2015
5	Interleukin-13IBA 01/2020 - 06/2003
5	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2005
5	Methacholine Chloride (Methacholine)FDA Link 05/2015 - 06/2003
4	VaccinesIBA 01/2021 - 01/2016
4	Peptides (Polypeptides)IBA 01/2020 - 08/2005
4	Messenger RNA (mRNA)IBA 01/2017 - 08/2006
4	Transcription Factors (Transcription Factor)IBA 02/2016 - 01/2006
4	AerosolsIBA 10/2009 - 09/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022 - 05/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2007
3	Therapeutic UsesIBA 07/2017 - 06/2003
3	Interleukin-4 (Interleukin 4)IBA 01/2017 - 06/2003
3	CollagenIBA 01/2014 - 04/2005
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 12/2021 - 07/2012
2	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2013
2	EnzymesIBA 01/2021 - 11/2020
2	Butyrates (Butyrate)IBA 11/2020 - 01/2017
2	HomocysteineIBA 01/2020 - 04/2010
2	Hormones (Hormone)IBA 01/2018 - 09/2016
2	Phosphates (Orthophosphate)IBA 01/2018 - 03/2014
2	Interleukin-2 (IL2)IBA 01/2018 - 01/2006
2	Cystatin CIBA 12/2017 - 09/2016
2	CreatinineIBA 12/2017 - 09/2016
2	InterleukinsIBA 01/2017 - 10/2011
2	RNA (Ribonucleic Acid)IBA 01/2017 - 10/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014 - 10/2011
2	Conjugated Linoleic AcidsIBA 01/2014 - 12/2010
2	Interleukin-10 (Interleukin 10)IBA 10/2011 - 06/2007
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2010 - 11/2007
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2009 - 04/2008
2	Immunoglobulin A (IgA)IBA 10/2009 - 02/2003
2	Arginine (L-Arginine)FDA Link 09/2009 - 05/2009
2	Toll-Like Receptor 2IBA 04/2008 - 03/2004
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2004 - 02/2003
1	OzoneIBA 01/2022

Therapy/Procedure

23	Therapeutics 01/2022 - 01/2007
6	Immunotherapy 12/2019 - 03/2002
2	Biological Therapy 01/2021 - 07/2017
1	Wearable Electronic Devices 01/2022
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2022